College Seeks FAA Waiver for Its Aviation Training Program

2026-06471 — Airworthiness Directives; The Boeing Company Airplanes

The FAA wants to make sure certain Boeing 757-200 airplanes stay safe by checking for cracks in the front cargo area frames, especially those with special cargo loading gear. They’re asking airlines to inspect or review maintenance records and do regular crack checks to catch problems early. Comments on this plan are open until May 18, 2026, and these inspections could mean some extra work and costs for operators.

2026-06459 — Airworthiness Directives; Ontic Engineering and Manufacturing, Inc. Airplanes (Type Certificate Previously Held by M7 Aerospace LLC)

The FAA wants Ontic Engineering and Manufacturing airplane owners to regularly check and fix the pitch trim actuator because some have failed during flight. These inspections and fixes must happen often to keep planes safe, and certain parts can’t be installed unless properly sealed. Comments on this plan are open until May 18, 2026, so owners should prepare for some maintenance costs and deadlines.

2026-06385 — Airworthiness Directives; The Boeing Company Airplanes

The FAA wants all Boeing 757-300 airplanes to get new inspections to catch cracks in key parts of the plane’s frame before they become a problem. Airlines will need to check for past repairs and do regular crack inspections to keep flights safe. Comments on this plan are open until May 18, 2026, and these checks might cost some time and money but will keep everyone flying safely.

2026-06377 — Notice of Final Action of Waiver With Respect to Land; DeWitt Field, Old Town Municipal Airport, Old Town, ME

The FAA has officially approved the release of federal rules on 1.74 acres of land at DeWitt Field in Old Town, Maine, which the city sold without permission in 2023. This means the city is no longer bound by FAA land-use rules for that property, but it doesn’t guarantee any FAA money for the sale. Airport officials and local folks can now move forward with this change, which was finalized in early 2026.

2026-06465 — Airworthiness Directives; Airbus Canada Limited Partnership (Type Certificate Previously Held by C Series Aircraft Limited Partnership (CSALP); Bombardier, Inc.) Airplanes

If you fly Airbus Canada Limited Partnership Model BD-500-1A10 or BD-500-1A11 planes, listen up! The FAA found a problem with a motor that controls air pressure, which could cause safety issues. Starting April 17, 2026, certain flights can’t take off if this motor or related alerts aren’t working right, so operators need to check carefully to keep everyone safe.

2026-06369 — Airworthiness Directives; Bell Textron Canada Limited Helicopters

If you own or fly a Bell Model 505 helicopter, listen up! The FAA found a problem where weights in the back could break loose and hit the tail rotor, which is super dangerous. Starting April 16, 2026, you can’t use those ballast weights anymore, and you’ll need to update your flight manual. This fix keeps everyone safe without costing a fortune, but don’t wait to make the change!

Previous: 2026-03491 — Agency Information Collection Activities: Requests for Comments; Clearance of Renewed Approval of Information Collection: Experimental Aircraft: Letters of Deviation Authority (LODA)

The FAA wants to keep collecting info from people who apply to teach flying in experimental aircraft for pay. They’re asking for your thoughts on how this process works and if it can be made easier or clearer. If you’re involved in flight instruction with these special planes, speak up by April 24, 2026—no extra fees, just your feedback!

Next: 2026-03493 — Issuance of Priority Review Voucher; Rare Pediatric Disease Product; WASKYRA (etuvetidigene autotemcel)

The FDA just gave a special fast-track prize called a Priority Review Voucher to Fondazione Telethon ETS for their rare disease treatment, WASKYRA, approved in December 2025. This medicine helps kids and adults with Wiskott-Aldrich Syndrome who need a stem cell transplant but can’t find a perfect donor. This voucher speeds up future drug reviews and can be sold, saving time and money for drug developers.